The use of ashwagandha tail uttarabasti for the treatment of prostatomegaly
Phase 2
- Conditions
- Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
- Registration Number
- CTRI/2024/06/068552
- Lead Sponsor
- Dr Suyesha Baburao Jadhav
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 50to 70 with no significant medical history
Patient having classical signs and symptoms of mootraghata/BPH like increase frequency urgency hesitancy weak stream of urine scanty micturation
Exclusion Criteria
Patients of malignancy congenital deformities of urogenital tract or any abdomino pelvic pathology other than BPH
Systemic disease like uncontrolled hypertension and diabetes mellitus will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method